Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Yes, both can interfere: vitamin C (ascorbic acid) supplements may falsely raise FreeStyle Libre 3 sensor glucose readings, while salicylic acid found in aspirin may falsely lower them. The effect depends on dose, with interference from vitamin C generally reported at intakes above 500 mg per day, so a multivitamin may matter less than a high-dose supplement. Timing, hydration, sensor age, and how far your reading strays from your symptoms all help you judge whether a number is trustworthy, and there are several important details to weigh before you treat a suspicious result. See below to understand more, including when to confirm with a fingerstick and when to contact your care team.
If your readings and your symptoms are not lining up, guessing can be risky, since acting on a falsely low or falsely high number can lead to overtreating, missed hypoglycemia, or unnecessary worry. A free, instant, online symptom check takes only a few minutes, helps you sort medication and supplement effects from a real glucose problem, and points you toward the right next step and the right level of care.
Last reviewed for medical accuracy: 09/13/2026
Continuous glucose monitors (CGMs) like the FreeStyle Libre 3 have transformed diabetes management by offering near–real-time glucose data without routine fingersticks. Still, it’s natural to wonder whether common supplements or medications—specifically vitamin C or aspirin—can interfere with sensor accuracy. Below, we review what the science and manufacturer data tell us, so you can use your FreeStyle Libre 3 with confidence.
Abbott, the maker of FreeStyle Libre 3, evaluates each sensor against a panel of common drugs and metabolites at concentrations well above what you’d normally see in your bloodstream. Their test results for Libre 3 indicate:
These findings closely mirror earlier data from Libre 1 and Libre 2 sensors, which demonstrated that ascorbic acid and salicylic acid—when tested at levels well above what you’d get from standard dosing—did not meaningfully alter glucose readings.
Even though vitamin C and aspirin are unlikely culprits, other real-world factors can impact your CGM readings:
Sensor placement
• Avoid areas with excessive scar tissue or low fat.
• Follow the insertion guide carefully to minimize inflammation.
Environmental conditions
• Extreme heat or cold can transiently affect sensor performance.
• Try to keep your reader or smartphone at room temperature.
Hydration status
• Severe dehydration may alter interstitial fluid dynamics.
• Stay well-hydrated, especially around sensor insertion time.
Compression
• Lying on your sensor (e.g., sleeping on your arm) can cause “compression lows.”
• If you see an unexplained dip, move your arm and wait for readings to rebound.
Follow insertion instructions
Ensure the sensor is clean, dry and secured to avoid peeling or dislodgement.
Check trends, not single points
A one-point glitch is less important than the overall pattern and trend arrows.
Do a fingerstick if in doubt
If your symptoms don’t match a reading—especially if it’s very low or very high—confirm with a blood glucose meter.
Update firmware and app
Keep your Libre 3 reader or smartphone app on the latest version for optimized algorithms.
Log suspect events
Note meals, exercise, medications (including supplements) and site compressions to help your care team spot patterns.
While vitamin C and aspirin are unlikely to throw off your Libre 3 readings in normal use, no device is 100% perfect. If you ever experience:
…please speak to a healthcare professional right away. You can also try a free, online symptom check, using the doctor approved Ubie Symptom Checker to help you decide on next steps.
Try a free, online symptom check, using the doctor approved Ubie Symptom Checker
Always remember: for anything life-threatening or serious, speak to a healthcare professional without delay. Your Freestyle Libre 3 is a powerful tool, and understanding its limits helps you manage your glucose safely and smartly.
(References)
* Lucarelli F, Ricci F, Caprio F, Valgimigli F, Scuffi C, Moscone D, Palleschi G. GlucoMen Day continuous glucose monitoring system: a screening for enzymatic and electrochemical interferents. J Diabetes Sci Technol. 2012 Sep 1;6(5):1172-81. doi: 10.1177/193229681200600522. Epub 2012 Sep 1. PMID: 23063044; PMCID: PMC3570852.
* Wada Y, Nakamura T, Kaneshige M, Takahashi S, Fujinaga H, Tsukamoto K, Ito Y, Sago H. Evaluation of two glucose meters and interference corrections for screening neonatal hypoglycemia. Pediatr Int. 2015 Aug;57(4):603-7. doi: 10.1111/ped.12543. Epub 2015 Feb 11. PMID: 25441549.
* Choi H, Naylon J, Luzio S, Beutler J, Birchall J, Martin C, Porch A. Design and In Vitro Interference Test of Microwave Noninvasive Blood Glucose Monitoring Sensor. IEEE Trans Microw Theory Tech. 2015 Oct 1;63(10 Pt 1):3016-3025. doi: 10.1109/TMTT.2015.2472019. PMID: 26568639; PMCID: PMC4641327.
* Heymann WR. Glucose Monitoring Dermopathy. Skinmed. 2018;16(1):74-75. Epub 2018 Feb 1. PMID: 29551122.
* Ba Y, Xu J, Yuan L, Zhu H, Yang Y, Lam MM, Zhang S, Xiao M, Xu J, Zhang R, Chen C. Assessment of the performance of blood glucose monitoring systems for monitoring dysglycaemia in neonatal patients. BMJ Paediatr Open. 2018;2(1):e000339. doi: 10.1136/bmjpo-2018-000339. Epub 2018 Oct 23. PMID: 30397671; PMCID: PMC6203032.
* Tummalapalli SL, Vittinghoff E, Hoggatt KJ, Keyhani S. Preventive Care Delivery After the Veterans Choice Program. Am J Prev Med. 2021 Jul;61(1):55-63. doi: 10.1016/j.amepre.2021.01.029. Epub 2021 Apr 2. PMID: 33820664; PMCID: PMC8217145.
* Falhammar H, Törring O, Larsson M, Nathanson D. Hypoglycemia after exposure of diclofenac medication. Endocrine. 2023 Mar;79(3):455-458. doi: 10.1007/s12020-022-03252-z. Epub 2022 Nov 14. PMID: 36374446.
* Benhalima K, Beunen K, Siegelaar SE, Painter R, Murphy HR, Feig DS, Donovan LE, Polsky S, Buschur E, Levy CJ, Kudva YC, Battelino T, Ringholm L, Mathiesen ER, Mathieu C. Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets. Lancet Diabetes Endocrinol. 2023 Jul;11(7):490-508. doi: 10.1016/S2213-8587(23)00116-X. Epub 2023 Jun 5. PMID: 37290466.
* Alva S, Bhargava A, Bode B, Brazg R, Castorino K, Kipnes M, Liljenquist DR, Tran H, Liu H, Nada M. Accuracy of a 15-day Factory-Calibrated Continuous Glucose Monitoring System With Improved Sensor Design. J Diabetes Sci Technol. 2026 Jul;20(4):1122-1130. doi: 10.1177/19322968251329364. Epub 2025 Apr 4. PMID: 40183340; PMCID: PMC11977615.
* Al-Othman SA, Al-Zaidany ZH, Al-Ghannam SH, Al-Turki AM, Al-Abdulazeem AA, Vatte C, Habara A, Al-Ali AK, Al-Awami MF. Determination of the Precision of Glucometers Used in Saudi Arabia. Sensors (Basel). 2025 Jun 5;25(11). doi: 10.3390/s25113561. Epub 2025 Jun 5. PMID: 40969070; PMCID: PMC12158352.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.